Skip to main content
Clinical Trials/NCT01955356
NCT01955356
Completed
Not Applicable

Evaluation of Induced Endometrial Injury in the Subsequent IVF Cycle.

Instituto Valenciano de Infertilidad, IVI VALENCIA1 site in 1 country600 target enrollmentOctober 2013
ConditionsSterility

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Sterility
Sponsor
Instituto Valenciano de Infertilidad, IVI VALENCIA
Enrollment
600
Locations
1
Primary Endpoint
Ongoing implantation rate (OIR)
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

Some studies have revealed that an induced endometrial injury could improve embryo human implantation in patients with implantation failure.

The purpose of this study is to determine whether the induced endometrial injury could be beneficial for regular patients undergoing IVF

Detailed Description

Endometrial induced injury has been suggested that could improve embryo implantation in cases of patients with recurrent implantation failure. The mechanisms that induce that improvement remain unknown. We want to analyse if the endometrial induce injury could be useful in cases of standard patients who require assisted reproductive techniques. For that purpose we will start a randomized controlled trial with the ideal background in implantation in ART, the egg donation programme.

Registry
clinicaltrials.gov
Start Date
October 2013
End Date
November 21, 2022
Last Updated
3 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Sponsor
Instituto Valenciano de Infertilidad, IVI VALENCIA
Responsible Party
Principal Investigator
Principal Investigator

Carmina Vidal, MD

Obstetrics and Gynecology

Instituto Valenciano de Infertilidad, IVI VALENCIA

Eligibility Criteria

Inclusion Criteria

  • 19-44 aged women
  • 19-29.9 Kg/m
  • 1st or 2nd fresh embryo transfer ( egg donation).
  • 1 or 2 blastocysts available.
  • written agreement.
  • \> or = 6 mms endometrial thickness.

Exclusion Criteria

  • Premature ovarian failure.
  • Endometrial pathology.
  • Insufficient endometrial development.
  • Hydrosalpinx
  • Mullerian malformations.

Outcomes

Primary Outcomes

Ongoing implantation rate (OIR)

Time Frame: 12 weeks of pregnancy

Secondary Outcomes

  • Live born rate (LBR)(9 months after embryo transfer)

Study Sites (1)

Loading locations...

Similar Trials